Top Health Care Reform Stories
Biosimilars and transparency can tame employers' $80,000-per-year drug bills
By Sharon FaustDisease-modifying antirheumatic drugs like Humira and Stelara now have more affordable competitors.
The latest news on health care reform and other regulation and compliance issues that are vital to benefits professionals. Insights and commentary about the latest proposals, and innovative strategies and ideas to ensure you stay focused on helping your customers while the debates rage on in Washington.
Disease-modifying antirheumatic drugs like Humira and Stelara now have more affordable competitors.